摘要
倍他乐克注射液作为β1受体阻滞的静脉制剂,因能尽早、尽快阻断交感神经系统β1受体活性,从而在一些急危重病人治疗中倍受关注。现就此作一概述。
Betaloc injection is a new one of intravenous beta-blockers.It can block sympathetic nervous activity as early quickly as possible.Here reviews a brief summary of therapeutic efficacy of betaloc in emergency and severe patients.
出处
《心血管病学进展》
CAS
2006年第z1期103-106,共4页
Advances in Cardiovascular Diseases
关键词
倍他乐克注射液
急危重病人
静脉应用
betaloc injection
emergency and severe patients
therapeutic efficacy
